Congratulations Cox lab!

CD30 co-stimulation drives differentiation of protective T cells during Mycobacterium #tuberculosis infection, say Taylor Foreman Taylor Foreman, Daniel Barber Daniel Barber, PhD and colleagues NIAID News bit.ly/3L5EOoT #TB

The University of Minnesota Medical School is looking for the next Director of the Center for Immunology (CFI-UMN)! Here's the link to apply for this opportunity: z.umn.edu/CFIDirector Please retweet!

Cool story!

1/ We are excited to share our report in Journal of Experimental Medicine showing that about 40% of cases of #WestNilevirus (#WNV) encephalitis are due to pre-existing auto-Abs neutralizing type I IFNs, making WNV encephalitis the best understood human infectious disease (rupress.org/jem/article/22…).

Aguilar lab is hiring a lab technician!! Please submit an application if you are interested in joining the Aguilar Lab ⁦UC San Francisco⁩ . Please share if you know someone who would be interested 🧪🧬🦠 aprecruit.ucsf.edu/JPF04601

Postdoc position available to work on M.tuberculosis and host inflammasome interactions (doi.org/10.1371/journa…). Experience with mouse model preferred. Salary >$60K depending on experience. Please RT.

Learn how a mycobacterial MFS transporter extracts hydrophobic triacylglycerides from the membrane and channels then into a periplasmic lipoprotein🤩Our story on the fascinating duo of Rv1410 and LprG is out now in Nature Communications 🥂🙌 nature.com/articles/s4146… #mycobacteria #CryoEM

This is a beautiful obituary to a world class immunologist. I read so much of his work as a student b/c it was technically superb and so creative. Albert Bendelac (1956-2023): Immunity cell.com/immunity/fullt…

Thanks for the great overview of the paper Russell! I’m super happy people get to finally read the paper and can’t wait to hear what other TB (and non-TB!) people think.

New STUDY researchsquare.com/article/rs-333… We reveal the presence of functionally diverse B cell subsets in TB disease lung tissue and suggest several potential localized roles that may represent a target for interventions to promote immunity or mitigate immunopathology.

Thanks Russell. Really happy to see this one out.

Now online! Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis dlvr.it/SzRhty

I implore global leaders to live up to their commitments. 1.6 million people die needlessly a year from this disease. It kills more people than war and malaria combined. And we can END IT as a global health threat forever. We have the tools. We need the funds to implement them.

Our paper estimating the infectiousness of subclinical tuberculosis and its contribution to transmission has now been published in elife. elifesciences.org/articles/82469

We are very happy to share our recently published work in ⁦Immunity⁩ on: Tissue factor binds to and inhibits interferon-α receptor 1 signaling. We show that TF-IFNAR1 within kidney plays an important thrombo-inflammatory switch for IFN response sciencedirect.com/science/articl…

Congratulations Anna-Lena!

Rare Variable M. tuberculosis Antigens induce predominant Th17 responses in human infection biorxiv.org/cgi/content/sh… #biorxiv_immuno

My first paper from grad school is out!! So grateful for the whole team, especially co-author Julian Yano, and other friends/colleagues who we got to work with on this paper Elizabeth Turcotte The Barton Lab

Attention TB friends! I am excited to be coorganizing the 2025 TB Keystone Symposia with joanne flynn and Henry Mwandumba. The theme is "Heterogeneity" and we look forward to seeing you there! Deadlines: Abstracts + Scholarships: 12 Nov 2024 Early Reg: 19 Dec 2024